Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10072334 | 0.94 | EPHX2 (0.59) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| SCHEMBL10072332 | 0.88 | EPHX2 (0.69) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| SCHEMBL15250808 | 0.88 | EPHX2 (0.65) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| SCHEMBL31686813 | 0.88 | EPHX2 (0.69) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| SCHEMBL19652437 | 0.88 | EPHX2 (0.69) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| SCHEMBL19652439 | 0.88 | EPHX2 (0.69) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| SCHEMBL2608068 | 0.88 | EPHX2 (0.69) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| SCHEMBL10057830 | 0.88 | EPHX2 (0.57) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| Hydrochloric Acid SCHEMBL6416042 | 0.87 | EPHX2 (0.68) | EPHX2SLC6A5LPAR1KDM4ECNR1 | |
| Hydrochloric Acid SCHEMBL4624712 | 0.87 | EPHX2 (0.68) | EPHX2SLC6A5LPAR1KDM4ECNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9815780-B2 | Quaternized fatty amines, amidoamines and their derivatives from natural oil | STEPAN COMPANY (US) | 2017-11-14 | — | — | US | disclosed |
| US-9416099-B2 | Quaternized fatty amines, amidoamines and their derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2016-08-16 | — | — | US | disclosed |
| US-20160024003-A1 | QUATERNIZED FATTY AMINES, AMIDOAMINES AND THEIR DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2016-01-28 | — | — | US | disclosed |
| US-20160016898-A1 | QUATERNIZED FATTY AMINES, AMIDOAMINES AND THEIR DERIVATIVES FROM NATURAL OIL METATHESIS | STEPHAN COMPANY (US) | 2016-01-21 | — | — | US | disclosed |
| US-9193936-B2 | Quaternized fatty amines, amidoamines and their derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2015-11-24 | — | — | US | disclosed |
| US-9006144-B2 | Glyphosate formulations based on compositions derived from natural oil metathesis | STEPAN COMPANY (US) | 2015-04-14 | — | — | US | disclosed |
| US-20130237421-A1 | GLYPHOSATE FORMULATIONS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY | 2013-09-12 | — | — | US | disclosed |
| US-20130225409-A1 | QUATERNIZED FATTY AMINES, AMIDOAMINES AND THEIR DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225409-A1 | QUATERNIZED FATTY AMINES, AMIDOAMINES AND THEIR DERIVATIVES FROM NATURAL OIL METATHESIS | ABHD5, ABHD6, SGMS1 | EPHX2 2113/4885SLC6A5 2666/4885LPAR1 671/4885 |
| US-20130237421-A1 | GLYPHOSATE FORMULATIONS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | DGAT2, DGAT1, GPR18 | EPHX2 1197/4885SLC6A5 69/4885LPAR1 77/4885 |
| US-20160024003-A1 | QUATERNIZED FATTY AMINES, AMIDOAMINES AND THEIR DERIVATIVES FROM NATURAL OIL METATHESIS | ABHD5, ABHD6, SGMS1 | EPHX2 1904/4885SLC6A5 2971/4885LPAR1 576/4885 |
| US-20160016898-A1 | QUATERNIZED FATTY AMINES, AMIDOAMINES AND THEIR DERIVATIVES FROM NATURAL OIL METATHESIS | ABHD5, ABHD6, SGMS1 | EPHX2 1849/4885SLC6A5 2785/4885LPAR1 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.